Brief: Elicio Therapeutics Publishes Preclinical Data On ELI-005
07/09/2022 13:15
Sept 7 (Reuters) - Elicio Therapeutics Inc ELTX.O :
* ELICIO THERAPEUTICS ANNOUNCES PUBLICATION OF PRECLINICAL
DATA ON
ELI-005, A LYMPH NODE-TARGETED AMPHIPHILE VACCINE AGAINST
SARS-COV-2
Source text for Eikon: ID:nGNX18GsM6
Further company coverage: ELTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elicio Therapeutics
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Elicio Therapeutics Q2 net loss narrows as R&D expenses fall
Elicio Therapeutics Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex
Elicio shares slide after pancreatic cancer vaccine falls short in mid-stage study (updated)